Further landmark evidence released to showcase the ability of Nightingale Health’s technology to predict hundreds of diseases from a single blood sample
Press release, 14 June 2022 at 9:20 a.m. (EEST) Nightingale Health Plc (“Nightingale Health”) announced today that its proprietary blood-testing technology has been used to conduct the largest scientific study of its kind showing the technology’s capability to predict hundreds of diseases from a single blood sample. The research, described in a new pre-print , is an important milestone in international efforts to realize the desperately needed benefits of preventative health to manage the massive cost and inequality